Literature DB >> 11369537

Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension.

N Palaniyar1, M Ikegami, T Korfhagen, J Whitsett, F X McCormack.   

Abstract

Surfactant protein A (SP-A) is an abundant protein found in pulmonary surfactant which has been reported to have multiple functions. In this review, we focus on the structural importance of each domain of SP-A in the functions of protein oligomerization, the structural organization of lipids and the surface-active properties of surfactant, with an emphasis on ultrastructural analyses. The N-terminal domain of SP-A is required for disulfide-dependent protein oligomerization, and for binding and aggregation of phospholipids, but there is no evidence that this domain directly interacts with lipid membranes. The collagen-like domain is important for the stability and oligomerization of SP-A. It also contributes shape and dimension to the molecule, and appears to determine membrane spacing in lipid aggregates such as common myelin and tubular myelin. The neck domain of SP-A is primarily involved in protein trimerization, which is critical for many protein functions, but it does not appear to be directly involved in lipid interactions. The globular C-terminal domain of SP-A clearly plays a central role in lipid binding, and in more complex functions such as the formation and/or stabilization of curved membranes. In recent work, we have determined that the maintenance of low surface tension of surfactant in the presence of serum protein inhibitors requires cooperative interactions between the C-terminal and N-terminal domains of the molecule. This effect of SP-A requires a high degree of oligomeric assembly of the protein, and may be mediated by the activity of the protein to alter the form or physical state of surfactant lipid aggregates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369537     DOI: 10.1016/s1095-6433(01)00309-9

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  17 in total

1.  Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.

Authors:  Guirong Wang; Svetla Taneva; Kevin M W Keough; Joanna Floros
Journal:  Biochim Biophys Acta       Date:  2007-07-06

2.  Variants of the SFTPA1 and SFTPA2 genes and susceptibility to tuberculosis in Ethiopia.

Authors:  S Malik; C M T Greenwood; T Eguale; A Kifle; J Beyene; A Habte; A Tadesse; H Gebrexabher; S Britton; E Schurr
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 3.  Recent advances in alveolar biology: evolution and function of alveolar proteins.

Authors:  Sandra Orgeig; Pieter S Hiemstra; Edwin J A Veldhuizen; Cristina Casals; Howard W Clark; Angela Haczku; Lars Knudsen; Fred Possmayer
Journal:  Respir Physiol Neurobiol       Date:  2010-04-28       Impact factor: 1.931

4.  Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress.

Authors:  Meenakshi Maitra; Yongyu Wang; Robert D Gerard; Carole R Mendelson; Christine Kim Garcia
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

5.  Synthesis of β-arabinofuranoside glycolipids, studies of their binding to surfactant protein-A and effect on sliding motilities of M. smegmatis.

Authors:  Kottari Naresh; Prakash Gouda Avaji; Krishnagopal Maiti; Binod K Bharati; Kirtimaan Syal; Dipankar Chatterji; Narayanaswamy Jayaraman
Journal:  Glycoconj J       Date:  2012-01-20       Impact factor: 2.916

Review 6.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

7.  Assessment of surfactant protein A (SP-A) dependent agglutination.

Authors:  Stefanie M Heinrich; Matthias Griese
Journal:  BMC Pulm Med       Date:  2010-11-22       Impact factor: 3.317

8.  Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.

Authors:  Elena Lopez-Rodriguez; Alicia Pascual; Raquel Arroyo; Joanna Floros; Jesus Perez-Gil
Journal:  Biophys J       Date:  2016-08-09       Impact factor: 4.033

9.  A 20-Mer Peptide Derived from the Lectin Domain of SP-A2 Decreases Tumor Necrosis Factor Alpha Production during Mycoplasma pneumoniae Infection.

Authors:  Usir S Younis; Hong Wei Chu; Monica Kraft; Julie G Ledford
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

10.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.